Clinical Trials Insight: 700009609
Latest Information Update: 20 Feb 2009
At a glance
- Drugs Bremelanotide (Primary)
- Indications Female sexual dysfunction
- Focus Therapeutic Use
- Sponsors Palatin Technologies; Pfizer
Latest Information Update: 20 Feb 2009